-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GTNIfDrxs3iNs6vr2SP/Jz22NFlnPwMp1TCEjO4DgUQn2v00YCRiOMk2kWisufQE otg4KUDnAtIXQ+rjDA0C0Q== 0000904454-01-500089.txt : 20010829 0000904454-01-500089.hdr.sgml : 20010829 ACCESSION NUMBER: 0000904454-01-500089 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010828 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WELSH CARSON ANDERSON & STOWE VII LP ET AL CENTRAL INDEX KEY: 0001012089 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 320 PARK AVENUE STREET 2: SUITE 2500 CITY: NEW YORK STATE: NY ZIP: 10022 MAIL ADDRESS: STREET 1: 320 PARK AVENUE STREET 2: SUITE 2500 CITY: NEW YORK STATE: NY ZIP: 10022 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 650271219 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-46595 FILM NUMBER: 1725587 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33326 SC 13D/A 1 f13d_3q-2001pediatrix.txt SCHEDULE 13D AMENDMENT NO. 2 CUSIP No. 705324 10 1 Page 1 of 6 Pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 2)1 Pediatrix Medical Group, Inc. - ------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.01 par value - ------------------------------------------------------------------------------- (Title of Class of Securities) 705324 10 1 - ------------------------------------------------------------------------------- (CUSIP Number) Welsh, Carson, Anderson Othon A. Prounis, Esq. & Stowe Reboul, MacMurray, Hewitt, 320 Park Avenue, Suite 2500 Maynard & Kristol New York, New York 10022 45 Rockefeller Plaza Attention: Jonathan Rather New York, New York 10111 Tel. (212) 893-9500 Tel. (212) 841-5700 - ------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 20, 2001 - ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [ ]. - -------- 1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 705324 10 1 Page 2 of 6 Pages 1) Name of Reporting Person Welsh, Carson, Ander- and I.R.S. Identification son & Stowe VII, L.P. No. of Above Person, if an Entity (Voluntary) - ------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [X] if a Member of a Group (b) [ ] - ------------------------------------------------------------------------------- 3) SEC Use Only - ------------------------------------------------------------------------------- 4) Source of Funds Not Applicable - ------------------------------------------------------------------------------- 5) Check if Disclosure of Legal Proceedings Is Not Applicable Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- 6) Citizenship or Place of Organization Delaware - ------------------------------------------------------------------------------- Number of 7) Sole Voting 2,757,877 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person ------------------------------------------------- 8) Shared Voting Power -0- ------------------------------------------------- 9) Sole Disposi- 2,757,877 shares of tive Power Common Stock ------------------------------------------------- 10) Shared Dis- positive Power -0- ------------------------------------------------- 11) Aggregate Amount Beneficially 2,757,877 shares of Owned by Each Reporting Person Common Stock - ------------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares - ------------------------------------------------------------------------------- 13) Percent of Class Represented by 11.7% Amount in Row (11) - ------------------------------------------------------------------------------- 14) Type of Reporting Person PN CUSIP No. 705324 10 1 Page 3 of 6 Pages 1) Name of Reporting Person WCAS Healthcare and I.R.S. Identification Partners, L.P. No. of Above Person, if an Entity (Voluntary) - ------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [X] if a Member of a Group (b) [ ] - ------------------------------------------------------------------------------- 3) SEC Use Only - ------------------------------------------------------------------------------- 4) Source of Funds Not Applicable - ------------------------------------------------------------------------------- 5) Check if Disclosure of Legal Proceedings Is Not Applicable Required Pursuant to Items 2(d) or 2(e) - ------------------------------------------------------------------------------- 6) Citizenship or Place of Organization Delaware - ------------------------------------------------------------------------------- Number of 7) Sole Voting 57,673 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person ------------------------------------------------- 8) Shared Voting Power -0- ------------------------------------------------- 9) Sole Disposi- 57,673 shares of tive Power Common Stock ------------------------------------------------- 10) Shared Dis- positive Power -0- ------------------------------------------------- 11) Aggregate Amount Beneficially 57,673 shares of Owned by Each Reporting Person Common Stock - ------------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares - ------------------------------------------------------------------------------- 13) Percent of Class Represented by 0.2% Amount in Row (11) - ------------------------------------------------------------------------------- 14) Type of Reporting Person PN CUSIP No. 705324 10 1 Page 4 of 6 Pages Amendment No. 2 to Schedule 13D ------------------------------- Reference is hereby made to the statement on Schedule 13D filed with the Commission on May 22, 2001, as amended by Amendment No. 1 thereto filed on May 29, 2001 (as so amended, the "Schedule 13D"). Terms defined in the Schedule 13D are used herein as so defined. Item 5 is hereby amended and restated to read in its entirety as follows: Item 5. Interest in Securities of the Issuer. ------------------------------------- The following information is based on a total of 23,640,542 shares of Common Stock outstanding as of August 7, 2001, as reported in the Issuer's Report on Form 10-Q for the period ended June 30, 2001 filed with the Commission on August 14, 2001: (a) WCAS VII and VII Partners ------------------------- WCAS VII owns 2,757,877 shares of Common Stock, or approximately 11.7% of the Common Stock outstanding. VII Partners, as the general partner of WCAS VII, may be deemed to beneficially own the securities owned by WCAS VII. WCAS HP and HP Partners ----------------------- WCAS HP owns 57,673 shares of Common Stock, or approximately 0.2% of the Common Stock outstanding. HP Partners, as the general partner of WCAS HP, may be deemed to beneficially own the securities owned by WCAS HP. General Partners of VII Partners and HP Partners ------------------------------------------------- (i) Patrick J. Welsh owns 23,892 shares of Common Stock, or approximately 0.1% of the Common Stock outstanding. (ii)Russell L. Carson owns 23,892 shares of Common Stock, or approximately 0.1% of the Common Stock outstanding. (iii) Bruce K. Anderson owns 23,892 shares of Common Stock, or approximately 0.1% of the Common Stock outstanding. (iv) Thomas E. McInerney owns 18,949 shares of Common Stock, or less than 0.1% of the Common Stock outstanding. (v) Robert A. Minicucci owns 8,238 shares of Common Stock, or less than 0.1% of the Common Stock outstanding. (vi) Anthony J. deNicola owns 2,471 shares of Common Stock, or less than 0.1% of the Common Stock outstanding. CUSIP No. 705324 10 1 Page 5 of 6 Pages (vii) Paul B. Queally owns 4,943 shares of Common Stock, or less than 0.1% of the Common Stock outstanding. (viii) Lawrence B. Sorrel owns no shares of Common Stock. (ix) Jonathan M. Rather owns no shares of Common Stock. (b) The general partners of VII Partners and HP Partners may be deemed to share the power to vote or direct the voting of and to dispose or direct the disposition of the Common Stock owned by WCAS VII and WCAS HP, respectively. Each of the general partners of VII Partners and HP Partners disclaims beneficial ownership of shares of Common Stock other than those he owns directly or by virtue of his or her indirect pro rata interest, as a general partner of VII Partners and/or HP Partners, as the case may be, in the securities owned by WCAS VII and/or WCAS HP. (c) On dates between August 14, 2001 and August 22, 2001, WCAS VII sold an aggregate 314,061 shares of Common Stock in open market transactions, at a weighted average sale price of $36.23 per share. (d) Except as described in this statement, no person has the power to direct the receipt of dividends on or the proceeds of sales of the shares of Common Stock owned by WCAS VII or WCAS HP. (e) Not Applicable. CUSIP No. 705324 10 1 Page 6 of 6 Pages Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. WELSH, CARSON, ANDERSON & STOWE VII, L.P. By: WCAS VII Partners, L.P., General Partner By: /s/ Jonathan Rather ------------------------- General Partner WCAS HEALTHCARE PARTNERS, L.P. By: WCAS HP Partners, General Partner By: /s/ Jonathan Rather ------------------------- Attorney-in-Fact Dated: August 28, 2001 -----END PRIVACY-ENHANCED MESSAGE-----